#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: respiratory syncytial virus (RSV)
#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
mRNA-based vaccine efficacious in preventing symptomatic RSV infection
1. In this randomized-controlled trial, an mRNA-based vaccine was efficacious at preventing symptomatic infection with respiratory syncytial virus (RSV) involving ...
#VisualAbstract: Nirsevimab prevents hospitalizations due to respiratory syncytial virus (RSV) in infants compared to standard care
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
#VisualAbstract: RSVpreF vaccine prevents RSV-associated illness in adults aged 60+
1. In this randomized controlled trial, respiratory syncytial virus prefusion F protein-based vaccine (RSVpreF) prevented RSV-associated lower respiratory tract illness ...
Ad26.RSV.preF-RSV vaccination prevents RSV infection in older adults
1. In this randomized controlled trial, vaccination with Ad26.RSV.preF-RSV preF protein was associated with significantly reduced respiratory syncytial virus (RSV) ...
RSV prefusion F protein vaccine is safe and effective in preventing RSV infection
1. A single dose of the respiratory syncytial virus (RSV) prefusion F protein vaccine had an acceptable safety profile in ...
#VisualAbstract: Respiratory syncytial virus vaccine shows high efficacy against lower respiratory tract disease in older adults
Click here to read this study in NEJM
Respiratory syncytial virus (RSV) vaccine produces transplacental neutralizing antibodies in pregnant women
1. The prefusion F protein of RSV (RSVpreF) vaccine produces neutralizing antibodies against RSV in both the serum of the ...
Prophylactic nirsevimab protects infants from respiratory syncytial virus infection
1. Single-dose intramuscular injection of nirsevimab significantly reduced respiratory syncytial virus (RSV) infection in infants. 2. Nirsevimab was shown to ...